COMPANY PROFILE // THE 014 REPORT
agilon health, inc.
AGL (NYSE) · Formerly: Agilon Health Topco, Inc.
Assembled from 2 government sources in 3.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-07-22: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-11-07 (last 24 months).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
agilon health, inc. is an SEC-registered operating company in services-misc health & allied services, nec, incorporated in DE, based in Westerville, OH; listed as AGL (NYSE).[source] It reported revenue of $5.93 billion for the fiscal year ended 2025-12-31.[source] It has filed 56 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are Clayton, Dubilier & Rice, LLC, North Peak Capital Management, LLC, BlackRock, Inc. (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 8-K Item 3.01 filed; 3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-07-22.[source]
- red0
- amber2
- info0
- Clayton, Dubilier & Rice, LLC$428.7M
- North Peak Capital Management, LLC$159.2M
- BlackRock, Inc.$122.9M
- AQR CAPITAL MANAGEMENT LLC$74.2M
- GOLDMAN SACHS GROUP INC$73.6M
- VANGUARD CAPITAL MANAGEMENT LLC$56.3M
- MARSHALL WACE, LLP$50.2M
- Durable Capital Partners LP$47.2M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Gertsch Timothy · Chief Accounting Officer (Officer) · latest Form 4 2025-08-19 · filing · LinkedIn search
- Schwaneke Jeffrey A. · Chief Financial Officer (Officer) · latest Form 4 2026-01-13 · filing · LinkedIn search
- Sell Steven · CEO & President (Director,Officer) · latest Form 4 2025-04-16 · filing · LinkedIn search
- Shaker Benjamin · Chief Markets Officer (Officer) · latest Form 4 2026-03-11 · filing · LinkedIn search
- Venkatachaliah Girish · Chief Technology Officer (Officer) · latest Form 4 2026-03-11 · filing · LinkedIn search
- Zamore Denise · Chief Legal Officer (Officer) · latest Form 4 2026-03-11 · filing · LinkedIn search
- Battaglia Silvana · Director · latest Form 4 2025-05-30 · filing · LinkedIn search
- MCKENZIE DIANA · Director · latest Form 4 2025-05-30 · filing · LinkedIn search
- Mansukani Sharad · Director · latest Form 4 2025-05-30 · filing · LinkedIn search
- McLoughlin Karen · Director · latest Form 4 2025-05-30 · filing · LinkedIn search
- WILLIAMS RONALD A · Director · latest Form 4 2025-05-30 · filing · LinkedIn search
- Wulf John William · Director · latest Form 4 2026-01-30 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001831097 | source |
| EIN | 37-1915147 | source |
| Business address (SEC) | 440 POLARIS PARKWAY, WESTERVILLE, OH, 43082 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-01 · in 101 days · Next 10-K due (period ended 2026-12-31; Large accelerated filer) (computed from the fiscal year end and filer status)
- 2027-05-10 · in 171 days · Next 10-Q due (period ended 2027-03-31; Large accelerated filer) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 8090 (services-misc health & allied services, nec): 15 companies in our records share this code.
federal dollars
SEC filings in 12 months
flags
Peers, each with its 014
- DAVITA INC. · 81 SEC filings in 12 months · $1.25B federal (possible match)
- Progyny, Inc. · 108 SEC filings in 12 months
- Sotera Health Co · 82 SEC filings in 12 months · 1 flag
- NewGenIvf Group Ltd · 82 SEC filings in 12 months
- Park Dental Partners, Inc. · 59 SEC filings in 12 months
- agilon health, inc. · 56 SEC filings in 12 months · 2 flags
- VIEMED HEALTHCARE, INC. · 49 SEC filings in 12 months
- MANGOCEUTICALS, INC. · 49 SEC filings in 12 months · 3 flags
- Fresenius Medical Care AG · 29 SEC filings in 12 months
- Marpai, Inc. · 28 SEC filings in 12 months
- CRYO CELL INTERNATIONAL INC · 22 SEC filings in 12 months · 1 flag
- Charming Medical Ltd · 15 SEC filings in 12 months
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- Cencora, Inc. · Battaglia Silvana
- VERTEX PHARMACEUTICALS INC / MA · MCKENZIE DIANA
- METLIFE INC · MCKENZIE DIANA
- BEST BUY CO INC · McLoughlin Karen
- Warby Parker Inc. · WILLIAMS RONALD A
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-16 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-11-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-05 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-22 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-06-03 filing 8-K items 5.07 · SEC EDGAR
- 2026-05-06 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-06 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-27 filing DEFA14A · SEC EDGAR
- 2026-04-27 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2026-04-23 filing ARS · SEC EDGAR
- 2026-04-23 filing DEFA14A · SEC EDGAR
- 2026-04-22 filing Proxy statement · SEC EDGAR
- 2026-03-30 filing 8-K items 3.03,5.03,9.01 · SEC EDGAR
- 2026-03-18 filing 8-K items 5.07,8.01,9.01 · SEC EDGAR
- 2026-02-25 filing Annual report (10-K) · SEC EDGAR
- 2026-02-25 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-02-20 filing DEFA14A · SEC EDGAR
- 2026-02-18 filing Proxy statement · SEC EDGAR
- 2026-02-12 filing 8-K items 1.01,2.03,9.01 · SEC EDGAR
- 2026-02-06 filing PRE 14A · SEC EDGAR
- 2026-01-07 officer change 8-K items 5.02 · SEC EDGAR
- 2025-11-07 filing 8-K items 3.01,7.01,9.01 · SEC EDGAR
- 2025-11-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-04 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2025-08-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-08-04 officer change 8-K items 2.02,5.02,5.03,7.01 · SEC EDGAR
- 2025-05-30 filing 8-K items 5.07 · SEC EDGAR
- 2025-05-30 insider First Form 3/4/5 on record for Battaglia Silvana (Director) · SEC Forms 3/4/5
107 earlier entries
- 2025-05-30 insider First Form 3/4/5 on record for MCKENZIE DIANA (Director)
- 2025-05-30 insider First Form 3/4/5 on record for Mansukani Sharad (Director)
- 2025-05-30 insider First Form 3/4/5 on record for McLoughlin Karen (Director)
- 2025-05-30 insider First Form 3/4/5 on record for WILLIAMS RONALD A (Director)
- 2025-05-30 insider First Form 3/4/5 on record for Wulf John William (Director)
- 2025-05-06 filing Quarterly report (10-Q)
- 2025-05-06 filing 8-K items 2.02,7.01,9.01
- 2025-05-06 filing DEFA14A
- 2025-04-17 filing ARS
- 2025-04-17 filing DEFA14A
- 2025-04-17 filing Proxy statement
- 2025-04-03 insider First Form 3/4/5 on record for Gertsch Timothy (Chief Accounting Officer)
- 2025-04-03 insider First Form 3/4/5 on record for Schwaneke Jeffrey A. (Chief Financial Officer)
- 2025-04-03 insider First Form 3/4/5 on record for Sell Steven (CEO & President)
- 2025-04-03 insider First Form 3/4/5 on record for Shaker Benjamin (Chief Markets Officer)
- 2025-04-03 insider First Form 3/4/5 on record for Venkatachaliah Girish (Chief Technology Officer)
- 2025-04-03 insider First Form 3/4/5 on record for Zamore Denise (Chief Legal Officer)
- 2025-02-25 filing Annual report (10-K)
- 2025-02-25 filing 8-K items 2.02,7.01,9.01
- 2024-12-05 filing 8-K items 1.01,8.01,9.01
- 2024-11-19 filing 8-K items 7.01,9.01
- 2024-11-07 filing Quarterly report (10-Q)
- 2024-11-07 filing 8-K items 2.02,7.01,9.01
- 2024-08-06 filing Quarterly report (10-Q)
- 2024-08-06 filing 8-K items 2.02,9.01
- 2024-06-05 officer change 8-K items 5.02,7.01,9.01
- 2024-06-03 filing 8-K items 5.07
- 2024-05-07 filing Quarterly report (10-Q)
- 2024-05-07 filing 8-K items 2.02,9.01
- 2024-04-18 filing ARS
- 2024-04-18 filing DEFA14A
- 2024-04-18 filing Proxy statement
- 2024-02-27 filing Annual report (10-K)
- 2024-02-27 filing 8-K items 2.02,7.01,9.01
- 2024-02-08 officer change 8-K items 5.02,9.01
- 2024-01-05 officer change 8-K items 5.02,7.01,9.01
- 2024-01-05 filing 8-K items 2.02,7.01,9.01
- 2023-11-14 filing 8-K items 7.01,9.01
- 2023-11-02 filing Quarterly report (10-Q)
- 2023-11-02 filing 8-K items 2.02,9.01
- 2023-09-12 filing 144
- 2023-08-16 officer change 8-K items 5.02
- 2023-08-08 filing 10-K/A
- 2023-08-03 filing Quarterly report (10-Q)
- 2023-08-03 filing 8-K items 2.02,9.01
- 2023-06-26 officer change 8-K items 5.02,8.01,9.01
- 2023-05-25 filing 8-K items 5.07
- 2023-05-18 filing 8-K items 8.01,9.01
- 2023-05-17 filing 424B7
- 2023-05-16 filing 144
- 2023-05-16 filing FWP
- 2023-05-15 filing 424B7
- 2023-05-15 filing 144
- 2023-05-15 filing S-3ASR
- 2023-05-12 filing DEFA14A
- 2023-05-09 filing Quarterly report (10-Q)
- 2023-05-09 filing 8-K items 2.02,9.01
- 2023-05-02 filing UPLOAD
- 2023-05-01 filing CORRESP
- 2023-04-24 filing UPLOAD
- 2023-04-20 filing 144
- 2023-04-19 filing 144
- 2023-04-14 filing DEFA14A
- 2023-04-14 filing Proxy statement
- 2023-04-03 filing CORRESP
- 2023-03-24 filing 144
- 2023-03-23 filing 144
- 2023-03-21 filing UPLOAD
- 2023-03-01 filing Annual report (10-K)
- 2023-03-01 filing 8-K items 2.02,9.01
- 2023-02-22 officer change 8-K items 5.02
- 2023-01-09 filing 8-K items 7.01
- 2022-12-20 officer change 8-K items 5.02
- 2022-11-03 filing Quarterly report (10-Q)
- 2022-11-03 filing 8-K items 2.02,9.01
- 2022-09-30 officer change 8-K items 5.02
- 2022-08-10 officer change 8-K items 5.02
- 2022-08-04 filing Quarterly report (10-Q)
- 2022-08-04 filing 8-K items 2.02,9.01
- 2022-05-24 filing 8-K items 5.07
- 2022-05-05 filing Quarterly report (10-Q)
- 2022-05-05 filing 8-K items 2.02,9.01
- 2022-04-28 officer change 8-K items 5.02
- 2022-04-11 filing DEFA14A
- 2022-04-11 filing Proxy statement
- 2022-03-03 filing Annual report (10-K)
- 2022-03-03 filing 8-K items 2.02,9.01
- 2022-02-14 officer change 8-K items 5.02
- 2022-02-07 officer change 8-K items 5.02
- 2022-01-10 filing 8-K items 7.01
- 2021-12-06 officer change 8-K items 5.02
- 2021-10-28 filing Quarterly report (10-Q)
- 2021-10-28 filing 8-K items 2.02,9.01
- 2021-09-13 filing 424B4
- 2021-09-09 filing EFFECT
- 2021-09-07 filing S-1/A
- 2021-08-30 filing Registration (S-1)
- 2021-08-04 filing Quarterly report (10-Q)
- 2021-08-04 filing 8-K items 2.02,9.01
- 2021-07-26 filing DRS
- 2021-07-12 officer change 8-K items 5.02,8.01,9.01
- 2021-05-26 filing Quarterly report (10-Q)
- 2021-05-26 filing 8-K items 2.02,9.01
- 2021-04-19 filing 8-K items 1.01,1.02,3.03,5.03,8.01,9.01
- 2021-04-16 filing 424B4
- 2021-04-14 filing EFFECT
- 2021-02-10 name change Name changed from Agilon Health Topco, Inc.
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-04 (within 30 days) 10-Q filed
- 2026-11-04 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-05 (older) 10-Q filed
- 2026-08-05 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-22 (older) 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-06-03 (older) 8-K filed: Item 5.07 shareholder vote
- 2026-05-06 (older) 10-Q filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NYSE:AGL The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1831097 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | AGL / NYSE | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 371915147 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001831097 | SEC EDGAR / IRS |
| CUSIP | 00857U206 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001831097 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $5,932,576,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 10:22 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$391,347,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 10:22 UTC | Report an error |
| Total assets (at 2025-12-31) | $1,271,290,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 10:22 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $126,734,000 | 2025-12-31 | 10-K, XBRL StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | as filed | 2026-11-20 10:22 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $173,713,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 10:22 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| SIC industry | 8090 Services-Misc Health & Allied Services, NEC | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Business address | 440 POLARIS PARKWAY, SUITE 550, WESTERVILLE, OH, 43082 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
| Exchanges | NYSE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 10:22 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$105,763,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 10:22 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $13,242,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 10:22 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $34,988,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-20 10:22 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $9,059,000 | 2024-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 10:22 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-04 · accession 0001628280-26-070141
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $1,519,486,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-04 | 0001628280-26-070141 | 2026-11-20 10:22 UTC | Report an error |
| Net income (loss) | $34,912,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-04 | 0001628280-26-070141 | 2026-11-20 10:22 UTC | Report an error |
| Interest expense | $1,744,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-04 | 0001628280-26-070141 | 2026-11-20 10:22 UTC | Report an error |
| Cash and cash equivalents | $174,399,000 | at 2026-09-30 | 10-Q | 2026-11-04 | 0001628280-26-070141 | 2026-11-20 10:22 UTC | Report an error |
| Debt due in the next 12 months (from an earlier report) | $19,250,000 | at 2025-12-31 | 10-K | 2026-02-25 | 0001628280-26-011655 | 2026-11-20 10:22 UTC | Report an error |
| Debt due in year 2 (from an earlier report) | $0 | at 2025-12-31 | 10-K | 2026-02-25 | 0001628280-26-011655 | 2026-11-20 10:22 UTC | Report an error |
| Debt due in year 3 (from an earlier report) | $15,750,000 | at 2025-12-31 | 10-K | 2026-02-25 | 0001628280-26-011655 | 2026-11-20 10:22 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-04 Filing 10-Q filed
- 2026-11-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-05 Filing 10-Q filed
- 2026-08-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-22 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-06-03 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-06 Filing 10-Q filed
- 2026-05-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-27 Filing DEFA14A filed
- 2026-04-27 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-04-23 Filing ARS filed
- 2026-04-23 Filing DEFA14A filed
- 2026-04-22 Filing DEF 14A filed
- 2026-03-30 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-03-18 Filing 8-K filed: Item 5.07 shareholder vote; Item 8.01 other event; Item 9.01 exhibits
- 2026-02-25 Filing 10-K filed
- 2026-02-25 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-02-20 Filing DEFA14A filed
- 2026-02-18 Filing DEF 14A filed
- 2026-02-12 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2026-02-06 Filing PRE 14A filed
- 2026-01-07 Filing 8-K filed: Item 5.02 officer or director change
- 2025-11-07 Filing 8-K filed: Item 3.01 delisting notice; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-11-04 Filing 10-Q filed
8-K item text, as filed (excerpts)
- 2026-11-16 8-K Item 7.01, Regulation FD Disclosure
agilon health, inc. will host a virtual investor event, including a presentation on Tuesday, November 17, 2026, at 2:00 PM, Eastern Time. A copy of the investor presentation is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. Interested investors and other parties may listen to a simultaneous webcast of the presentation on Tuesday, November 17th by visiting the “Events & Presentations” section of agilon health’s investor relations website at https://investors.agilonhealth.com. Replays will be available for on-demand listening shortly after the completion of the presentation. The information set forth in Item 7.01 of this Current Report on Form 8-K and the related… the 8-K · retrieved 2026-11-20 10:22 UTC - 2026-11-04 8-K Item 2.02, Results of Operations and Financial Condition
On November 4, 2026, agilon health, inc. (the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three and nine months ended September 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. The information set forth in Item 2.02 of this Current Report on Form 8-K and the related information in Exhibits 99.1 attached hereto is being furnished herewith, and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference… the 8-K · retrieved 2026-11-20 10:22 UTC - 2026-08-05 8-K Item 2.02, Results of Operations and Financial Condition
On August 5, 2026, agilon health, inc. (the “Company”), a Delaware corporation, issued a press release setting forth its financial results for the three and six months ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. The information set forth in Item 2.02 of this Current Report on Form 8-K and the related information in Exhibits 99.1 attached hereto is being furnished herewith, and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any… the 8-K · retrieved 2026-11-20 10:22 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Clayton, Dubilier & Rice, LLC | $428,720,000 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 2 | North Peak Capital Management, LLC | $159,169,374 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 3 | BlackRock, Inc. | $122,884,014 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 4 | AQR CAPITAL MANAGEMENT LLC | $74,226,574 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 5 | GOLDMAN SACHS GROUP INC | $73,610,338 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $56,304,655 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 7 | MARSHALL WACE, LLP | $50,191,644 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 8 | Durable Capital Partners LP | $47,228,010 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 9 | D. E. Shaw & Co., Inc. | $41,816,170 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $37,401,533 | 2026-06-30 | SEC 13F filing | 2026-11-20 10:22 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1831097.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001831097. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.